title: Robust and sustained immune activation in human Ebola virus infection.
authors: Department of Physiology, and Complex Traits Group, McGill University, Montreal, QC, Canada H3G 0B1; and.
authors: Judith N
authors: JN
authors: Mandl
authors: Merck Vaccines, Merck & Company, Inc., West Point, PA 19486 mark_feinberg@merck.com.
authors: Mark B
authors: MB
authors: Feinberg
mesh_terms: D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D029043:Ebolavirus / Q000276:immunology*; D019142:Hemorrhagic Fever, Ebola / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology*